Nearly 23 million U.S. adults with blood pressure readings of 130/80 mm Hg or higher may qualify for blood-pressure-lowering medications under updated clinical recommendations, according to independent research published in the Journal of the American Heart Association. The findings highlight a substantial treatment gap, as over 40% of patients who meet the updated criteria currently … Read more
The updated ABCs of cardiovascular disease (CVD) prevention framework, published in the American Journal of Preventive Cardiology in 2026, provides a standardized, evidence-based roadmap for clinicians to manage heart health across a patient’s lifespan. By integrating tools like the PREVENT™ risk scoring system and addressing Cardiovascular-Kidney-Metabolic (CKM) syndrome, the framework shifts clinical focus toward early, … Read more
The American Heart Association and the American College of Cardiology have introduced the first clinical practice guideline for cardiovascular-kidney-metabolic (CKM) syndrome, a framework designed to identify and manage the interconnected risks of heart, kidney, and metabolic diseases. Nearly 90% of U.S. adults possess at least one risk factor for the condition, such as obesity, high … Read more
New research involving 31,041 adults with type 2 diabetes suggests that dihydropyridine calcium-channel-blockers (DCCBs), a common class of blood pressure medication, may be associated with a 33% higher risk of major adverse kidney events. This finding raises questions about the long-term safety of using these drugs as secondary treatments for hypertension in patients already receiving … Read more
Rethinking Blood Pressure Management in Diabetic Kidney Disease For millions of people living with type 2 diabetes (T2D), managing blood pressure is a critical, daily necessity. High blood pressure acts as a silent accelerator for diabetic kidney disease (DKD), a condition that gradually compromises the kidneys’ ability to filter waste from the blood. However, recent … Read more
Revolutionizing Kidney Disease Diagnosis: New Study Validates Diagnostic Thresholds and Highlights Combined Testing Benefits Recent research from Karolinska Institutet and Leiden University Medical Center has reaffirmed the clinical relevance of current diagnostic thresholds for chronic kidney disease (CKD), while emphasizing the advantages of combining two blood tests to improve risk assessment. The findings, published in … Read more
The New Face of Kidney Health: From Rare Condition to Public Health Crisis For a long time, severe kidney disease was viewed as a condition affecting a specific, limited population. Still, the landscape is shifting. Experts now warn that kidney disease has emerged as a major public health concern, driven by a perfect storm of … Read more
The Hidden Shift: Why “Normal” Fitness Isn’t the Whole Story For years, the benchmark for health in adolescents with type 1 diabetes has focused heavily on glycemic control and overall physical capacity. If a teenager can keep up with their peers on the soccer field or in the gym, it is often assumed that their … Read more
The Quiet Health Crisis: Why Routine Screening is the Future of Preventative Care Millions of Americans are navigating life unaware of underlying health conditions. It’s not that these conditions are hidden, but rather that many haven’t had a reason to look for them. The growing evidence suggests that proactive health screening isn’t just beneficial – … Read more
The Silent Threat: How Young Adult Blood Pressure Shapes Lifelong Heart and Kidney Health New research presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026 reveals a concerning link between blood pressure levels in young adulthood and the risk of developing heart and kidney disease later in life. The findings underscore the critical importance … Read more